Knockdown of IFI16 or treatment with gemcitabine moderately reduced the growth rate of orthotopic tumors of PAAD in mice, while the efficacy of gemcitabine in suppressing PAAD tumor was largely improved when IFI16 was knocked down (Figure 6C). This evidence concerns the gene IFI16 and pancreatic adenocarcinoma.